Ridgeback Capital Investments L.P. 13D and 13G filings for F-star Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Unchanged | 2022-12-31 | 13G | F-star Therapeutics, Inc. FSTX | Ridgeback Capital Investments L.P. | 52,509 0.200% | 0 (Unchanged) | Filing |
| 2023-02-14 4:02 pm Sale | 2022-12-31 | 13G | F-star Therapeutics, Inc. FSTX | Ridgeback Capital Investments L.P. | 52,509 0.200% | -1,781,851 (-97.14%) | Filing |
| 2022-02-14 4:15 pm Purchase | 2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX | Ridgeback Capital Investments L.P. | 1,834,360 8.900% | 1,340,000 (+271.06%) | Filing |
| 2021-04-09 4:54 pm Purchase | 2021-03-30 | 13G | F-star Therapeutics, Inc. FSTX | Ridgeback Capital Investments L.P. | 494,360 5.400% | 86,793 (+21.30%) | Filing |
| 2021-02-16 4:20 pm Purchase | 2020-12-31 | 13G | F-star Therapeutics, Inc. FSTX | Ridgeback Capital Investments L.P. | 407,567 4.500% | 407,567 (New Position) | Filing |